Full View

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

M Shiota, A Yokomizo, E Kashiwagi, Y Tada… - Cancer …, 2010 - Wiley Online Library
Many advanced cancers receive cisplatin‐based chemotherapy. However, cisplatin
resistance is a major obstacle for cancer chemotherapy. Foxo3a is a member of the Foxo …
被引用次数：67 相关文章

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

M Shiota, A Yokomizo, E Kashiwagi… - Cancer …, 2010 - pubmed.ncbi.nlm.nih.gov
Many advanced cancers receive cisplatin-based chemotherapy. However, cisplatin
resistance is a major obstacle for cancer chemotherapy. Foxo3a is a member of the Foxo …

[引用][C] Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

M SHIOTA, A YOKOMIZO, E KASHIWAGI… - Cancer …, 2010 - pascal-francis.inist.fr
Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

M Shiota, A Yokomizo, E Kashiwagi, Y Tada… - Cancer Science, 2010 - cir.nii.ac.jp
抄録< jats: p> Many advanced cancers receive cisplatin‐based chemotherapy. However,
cisplatin resistance is a major obstacle for cancer chemotherapy. Foxo3a is a member of the …

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin.

M Shiota, A Yokomizo, E Kashiwagi, Y Tada… - Cancer …, 2010 - europepmc.org
Many advanced cancers receive cisplatin-based chemotherapy. However, cisplatin
resistance is a major obstacle for cancer chemotherapy. Foxo3a is a member of the Foxo …
[HTML] nih.gov

[HTML][HTML] Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

M Shiota, A Yokomizo, E Kashiwagi, Y Tada… - Cancer …, 2010 - ncbi.nlm.nih.gov
Many advanced cancers receive cisplatin‐based chemotherapy. However, cisplatin
resistance is a major obstacle for cancer chemotherapy. Foxo3a is a member of the Foxo …

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

M Shiota, A Yokomizo, E Kashiwagi… - Cancer …, 2010 - kyushu-u.elsevierpure.com
Many advanced cancers receive cisplatin-based chemotherapy. However, cisplatin
resistance is a major obstacle for cancer chemotherapy. Foxo3a is a member of the Foxo …

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

M Shiota, A Yokomizo, E Kashiwagi, Y Tada, J Inokuchi… - Cancer Science, 2010 - infona.pl
Many advanced cancers receive cisplatin‐based chemotherapy. However, cisplatin
resistance is a major obstacle for cancer chemotherapy. Foxo3a is a member of the Foxo …
[PDF] academia.edu

[PDF][PDF] Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

M Shiota, A Yokomizo, E Kashiwagi, Y Tada, J Inokuchi… - Cancer Sci, 2010 - academia.edu
Materials and Methods Cell culture. Human bladder cancer T24, KK47, T24⁄ DDP10, and
KK47⁄ DDP20 cells were cultured in Eagle's minimal essential medium, which was …

[引用][C] Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

S Masaki, Y Akira, K Eiji, T Yasuhiro, I Junichi… - Cancer science, 2010 - cir.nii.ac.jp
Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …